| abstract |
Disclosed is the use of a composition, which, depending on the consumer, can be in the form of a dietary, pharmaceutical or veterinary product and includes Streptococcus thermophilus and at least one strain of the following bacteria: Lactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobiferium longis infantis, Bifidobacterium infantis, Bifidobacterium infantis, Bifidobacterium infantis, Bifidobacterium infantis, Bifidobacterium infantis, breve for the prevention and / or treatment of hyperoxaluria and disorders associated with it, and also provides a method for the prevention and / or treatment of this disease by introducing to the patient 0.5-4 g / day of the specified composition. |